( CNN) Immunotherapy has gained ground against a adamant dissident: ovarian cancer. A personalized cancer inoculation is safe and may expand the well-being of ovarian cancer cases, a small clinical tribulation experienced.
The investigate, published Wednesday in the publication Science Translational Medicine, testified “significantly higher” overall survival at two years among patients who received the inoculation, compared with patients who did not.
Ovarian cancer is a “silent killer” because often it leads unnoticed until it is diagnosed at a late stage. Given with surgery followed by chemotherapy, most patients — 85% — relapse and ultimately develop fight to the chemo. At this top, they run out of medicine options.